TiGenix announces six-month Phase I/II results of AlloCSC-01 in Acute Myocardial Infarction
Jun 17, 2016 18:40 pm UTC| Business
Leuven, Belgium, June 17, 2016 -- TiGenix NV (Euronext Brussels:TIG), an advanced biopharmaceutical company focused on the development and commercialization of novel therapeutics from its proprietary platforms of...
Associa Arizona Selected to Manage IronOaks at Sun Lakes
Jun 17, 2016 18:33 pm UTC| Business
SUN LAKES, Ariz., June 17, 2016 -- Associa Arizona is proud to announce it has been awarded the management contract for the esteemed Sun Lakes active adult community of IronOaks. Full management services begin June 20...
Proving Success, Northeast Farm to School Institute to Run Second Year
Jun 17, 2016 16:15 pm UTC| Business
SHELBURNE, Vt., June 17, 2016 -- Vermont Food Education Every Day (VT FEED, a collaboration of Shelburne Farms and NOFA-VT) will host its second annual Northeast Farm to School Institute, a year-long learning opportunity...
First Real-Time Patient Monitoring in NY/NJ Area
Jun 17, 2016 14:38 pm UTC| Business
TEANECK, N.J., June 17, 2016 -- Holy Name Medical Center is the first hospital in the NY/NJ metropolitan area to use digital monitoring technology to continuously track patients' vital signs. The ViSi Mobile device, about...
NEP Acquires Broadcast Solutions Group
Jun 17, 2016 13:05 pm UTC| Business
PITTSBURGH, June 17, 2016 -- NEP Group Inc. ('NEP') announced today that it has entered into a definitive agreement to acquireBroadcast Solutions Group ("Broadcast Solutions"), the global provider of outside broadcast...
Jun 17, 2016 12:44 pm UTC| Business
SYRACUSE, N.Y., June 17, 2016 -- Syracuse University's S. I. Newhouse School of Public Communications today announced, in partnership with Medtronic, a global medical technology company, and WCG, an integrated...
Auris Medical Initiates ASSENT Phase 3 Trial of AM-111 for Treatment of Sudden Deafness
Jun 17, 2016 12:09 pm UTC| Business
ZUG, Switzerland, June 17, 2016 -- Auris Medical Holding AG (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced it has...